Polymorphism Clinical Trial
Official title:
Polymorphids and mRNA Expression in Genes, Significant for Developing Obesity and Typ II Diabetes in Different Types/Localisations of Fat Tissue
Fat tissue from omenta, thigh and abdomen taken under anesthesia on subjects undergoing
laparoscopic surgery, cholecystectomy, reflux surgery or gastric by-pass (GBP).
Are there any difference in polymorphids and/or mRNA expression in genes significant for
developing obesity, between normal weight and obese individuals, with or without diabetes
typ 2 .
Are there any difference in polymorphids and/or mRNA expression in different types of fat
tissue
n/a
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03859882 -
Protocol PERCAF 2018
|
N/A | |
Recruiting |
NCT03114826 -
Study of the Impact of VEGF Polymorphism on the Development of Renal Carcinoma in Renal Transplant Patients
|
N/A | |
Suspended |
NCT01137136 -
Aromatase (CYP19) Polymorphism Between AI-responsive and AI-resistant Breast Cancer in Korea
|
N/A | |
Completed |
NCT02743468 -
Cytochrome P450 Epoxygenase Pathway Regulation of Macrophage Function
|
||
Completed |
NCT01239914 -
CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT)
|
||
Completed |
NCT03855774 -
Polymorphisms, Caffeine and Sleep Disorders
|
N/A | |
Recruiting |
NCT04565834 -
Effect of Genetic Alterations in Key Genes in the Kynurenine Pathway on Suicidal Behavior
|
||
Not yet recruiting |
NCT03262363 -
Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy
|
Phase 2/Phase 3 |